These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 33166734)

  • 1. Naringin and naringenin as anticancer agents and adjuvants in cancer combination therapy: Efficacy and molecular mechanisms of action, a comprehensive narrative review.
    Memariani Z; Abbas SQ; Ul Hassan SS; Ahmadi A; Chabra A
    Pharmacol Res; 2021 Sep; 171():105264. PubMed ID: 33166734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive review on naringenin and naringin polyphenols as a potent anticancer agent.
    Rauf A; Shariati MA; Imran M; Bashir K; Khan SA; Mitra S; Emran TB; Badalova K; Uddin MS; Mubarak MS; Aljohani ASM; Alhumaydhi FA; Derkho M; Korpayev S; Zengin G
    Environ Sci Pollut Res Int; 2022 May; 29(21):31025-31041. PubMed ID: 35119637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A narrative review on Naringin and Naringenin as a possible bioenhancer in various drug-delivery formulations.
    Ganesh P; Suresh V; Narasimhan MK; Sabarathinam S
    Ther Deliv; 2023 Dec; 14(12):763-774. PubMed ID: 38088094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Potential Role of Naringin and Naringenin as Nutraceuticals Against Metabolic Syndrome.
    Massaro L; Raguzzini A; Aiello P; Valencia DV
    Endocr Metab Immune Disord Drug Targets; 2023; 23(4):428-445. PubMed ID: 36043734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-treatment of THP-1 cells with naringenin and curcumin induces cell cycle arrest and apoptosis via numerous pathways.
    Shi D; Xu Y; Du X; Chen X; Zhang X; Lou J; Li M; Zhuo J
    Mol Med Rep; 2015 Dec; 12(6):8223-8. PubMed ID: 26496980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical evidence for the pharmacological actions of naringin: a review.
    Bharti S; Rani N; Krishnamurthy B; Arya DS
    Planta Med; 2014 Apr; 80(6):437-51. PubMed ID: 24710903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highlights in Resistance Mechanism Pathways for Combination Therapy.
    Delou JMA; Souza ASO; Souza LCM; Borges HL
    Cells; 2019 Aug; 8(9):. PubMed ID: 31480389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer Potential of Naringenin, Biosynthesis, Molecular Target, and Structural Perspectives.
    Prakash O; Singh R; Singh N; Usmani S; Arif M; Kumar R; Ved A
    Mini Rev Med Chem; 2022; 22(5):758-769. PubMed ID: 34517796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of colorectal carcinogenesis by naringin.
    Ansari B; Aschner M; Hussain Y; Efferth T; Khan H
    Phytomedicine; 2022 Feb; 96():153897. PubMed ID: 35026507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: An update.
    Joshi R; Kulkarni YA; Wairkar S
    Life Sci; 2018 Dec; 215():43-56. PubMed ID: 30391464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naringenin and naringin in cardiovascular disease prevention: A preclinical review.
    Heidary Moghaddam R; Samimi Z; Moradi SZ; Little PJ; Xu S; Farzaei MH
    Eur J Pharmacol; 2020 Nov; 887():173535. PubMed ID: 32910944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naringenin: A potential flavonoid phytochemical for cancer therapy.
    Motallebi M; Bhia M; Rajani HF; Bhia I; Tabarraei H; Mohammadkhani N; Pereira-Silva M; Kasaii MS; Nouri-Majd S; Mueller AL; Veiga FJB; Paiva-Santos AC; Shakibaei M
    Life Sci; 2022 Sep; 305():120752. PubMed ID: 35779626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidiabetic Properties of Naringenin: A Citrus Fruit Polyphenol.
    Den Hartogh DJ; Tsiani E
    Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30871083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin-like antidiabetic, cardio-protective and non-glycemic effects of naringenin: Molecular and pharmacological insights.
    Nyane NA; Tlaila TB; Malefane TG; Ndwandwe DE; Owira PMO
    Eur J Pharmacol; 2017 May; 803():103-111. PubMed ID: 28322845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver Disease.
    Naeini F; Namkhah Z; Ostadrahimi A; Tutunchi H; Hosseinzadeh-Attar MJ
    Adv Nutr; 2021 Mar; 12(2):413-428. PubMed ID: 32879962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review on Pharmacological and Analytical Aspects of Naringenin.
    Patel K; Singh GK; Patel DK
    Chin J Integr Med; 2018 Jul; 24(7):551-560. PubMed ID: 25501296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices.
    So FV; Guthrie N; Chambers AF; Moussa M; Carroll KK
    Nutr Cancer; 1996; 26(2):167-81. PubMed ID: 8875554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combating oxidative stress disorders with citrus flavonoid: Naringenin.
    Zaidun NH; Thent ZC; Latiff AA
    Life Sci; 2018 Sep; 208():111-122. PubMed ID: 30021118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naringin and Naringenin: Their Mechanisms of Action and the Potential Anticancer Activities.
    Stabrauskiene J; Kopustinskiene DM; Lazauskas R; Bernatoniene J
    Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naringenin as potent anticancer phytocompound in breast carcinoma: from mechanistic approach to nanoformulations based therapeutics.
    Elsori D; Pandey P; Ramniwas S; Kumar R; Lakhanpal S; Rab SO; Siddiqui S; Singh A; Saeed M; Khan F
    Front Pharmacol; 2024; 15():1406619. PubMed ID: 38957397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.